dasabuvir
Selected indexed studies
- Dasabuvir. (, 2006) [PMID:29999876]
- Clinical Pharmacokinetics of Dasabuvir. (Clin Pharmacokinet, 2017) [PMID:28258380]
- Mechanism of dasabuvir inhibition of acetaminophen glucuronidation. (J Pharm Pharmacol, 2022) [PMID:34718654]
_Worker-drafted node — pending editorial review._
Connections
dasabuvir is a side effect of
Sources
- Dasabuvir. (2006) pubmed
- Clinical Pharmacokinetics of Dasabuvir. (2017) pubmed
- Mechanism of dasabuvir inhibition of acetaminophen glucuronidation. (2022) pubmed
- Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids. (2021) pubmed
- Dasabuvir (ABT333) for the treatment of chronic HCV genotype I: a new face of cure, an expert review. (2016) pubmed
- Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1. (2023) pubmed
- Dasabuvir: An FDA-approved drug inhibiting poxvirus transmission by targeting both migrasome formation and extracellular enveloped virus production. (2025) pubmed
- Dasabuvir alleviates 5-fluorouracil-induced intestinal injury through anti-senescence and anti-inflammatory. (2024) pubmed
- Dengue virus: pathogenesis and potential for small molecule inhibitors. (2024) pubmed
- PMID:28609079 (2015) pubmed